TricValve®
Transcatheter Bicaval Valves System
CE Certified and ANVISA approved in Brazil
TricValve® – Transcatheter Bicaval Valves System is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. It is intended for patients with severe TR at high risk or who are inoperable for open surgical therapy.
TricValve® – Transcatheter Bicaval Valves System is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. It is intended for patients with severe TR at high risk or who are inoperable for open surgical therapy.
TricValve is a heterotopic solution where the valves are percutaneously implanted into the right atrium and anchored via the long stents in the vena cava to ensure correct positioning in the right atrium. This prevents valve displacement without disturbing the native tricuspid valve.
Vienna Aortic Valve SE
Self-expandable Transcatheter Valve System
The Vienna Aortic Valve SE – Self-expandable Transcatheter Valve System is designed to treat severe aortic stenosis in patients at medium to high risk for open heart surgery. The minimally invasive heart valve replaces the native valve without the need for concomitant surgical removal and is placed through femoral access. The new generation device comes fully premounted with specially prepared bovine pericardium, thus reducing preparation steps and procedure time.